Franco Locatelli

Active 1991–2026

506
Papers
59,349
Citations
130
h-index
479
i10-index

Citations

Citations per year for Franco Locatelli1982: 1 citations1985: 1 citations1988: 1 citations1991: 4 citations1993: 1 citations1994: 1 citations1996: 1 citations1997: 10 citations1998: 12 citations1999: 12 citations2000: 26 citations2001: 31 citations2002: 66 citations2003: 78 citations2004: 99 citations2005: 131 citations2006: 128 citations2007: 175 citations2008: 213 citations2009: 267 citations2010: 346 citations2011: 377 citations2012: 350 citations2013: 430 citations2014: 339 citations2015: 432 citations2016: 347 citations2017: 419 citations2018: 368 citations2019: 1,468 citations2020: 2,006 citations2021: 2,602 citations2022: 2,200 citations2023: 1,496 citations2024: 2,748 citations2025: 1,340 citations2026: 41 citations1983–1984: no citations, so these years are not shown1986–1987: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992: no citations, so this year is not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,343 citing papers, 21.3% of this breakdownItaly: 2,234 citing papers, 8.9% of this breakdownChina: 2,146 citing papers, 8.5% of this breakdownGermany: 1,641 citing papers, 6.5% of this breakdownUnited Kingdom: 1,515 citing papers, 6% of this breakdownFrance: 1,165 citing papers, 4.6% of this breakdownNetherlands: 864 citing papers, 3.4% of this breakdownCanada: 752 citing papers, 3% of this breakdownSpain: 719 citing papers, 2.9% of this breakdownAustralia: 607 citing papers, 2.4% of this breakdownSwitzerland: 559 citing papers, 2.2% of this breakdownJapan: 548 citing papers, 2.2% of this breakdown
0%21.3%Other 28.1%

Fields

  • Medicine67.3%
  • Biochemistry, Genetics and Molecular Biology17%
  • Immunology and Microbiology12.6%
  • Neuroscience0.8%
  • Engineering0.6%
  • Computer Science0.4%
  • Other1.3%

Topics

  • Immune Cell Function and Interaction5.2%
  • Hematopoietic Stem Cell Transplantation5%
  • CAR-T cell therapy research4.7%
  • Mesenchymal stem cell research3.9%
  • Acute Lymphoblastic Leukemia research3.5%
  • Acute Myeloid Leukemia Research3.2%
  • Other74.5%

Coauthors

All papers

Open in search
  1. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,856

  2. GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Rabusin, Katia Perruccio, Veronica Folsi, Concetta Quintarelli, Franco Locatelli - New England Journal of Medicine 2023 cited by 533

  3. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 960

  4. Exagamglogene Autotemcel for Severe Sickle Cell Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 380

  5. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 499

  6. Betibeglogene Autotemcel Gene Therapy for Non–β 0 /β 0 Genotype β-Thalassemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 258

  7. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 511

  8. Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 266

  9. Advancements and challenges in CAR T cell therapy in autoimmune diseases

    Authors: , , , , , , , , , , , , , - Nature Reviews Rheumatology 2024 cited by 209

  10. NK cells and ILCs in tumor immunotherapy

    Authors: , , , , , , , , , , - Molecular Aspects of Medicine 2020 cited by 275

  11. Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications

    Authors: , , , , - Cell Death and Differentiation 2019 cited by 395

  12. Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 204

  13. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2021 cited by 325

  14. Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 186

  15. Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation

    Authors: , , , , , , , , , , , , - Frontiers in Immunology 2019 cited by 382

  16. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

    Authors: , , , , , , , , , , , , , , - The Lancet 2008 cited by 2,706

  17. Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2022 cited by 119

  18. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicola De Rossi, Amedeo Guzzardella, Carlo Valsecchi, Fabiana Madotto, Francesca Bevilacqua, Marco Di Laudo, Lorenzo Querci, Carmen Seccafico - The Lancet Respiratory Medicine 2020 cited by 736

  19. Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 605

  20. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 299

  21. Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adriana Balduzzi, on behalf of the I-BFM SCT Study Group, Selim Corbacioglu, on behalf of the EBMT Paediatric Diseases Working Party, Peter Bader - Journal of Clinical Oncology 2020 cited by 329

  22. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Krisztián Kállay, Owen Smith, Válerie de Haas, Gudrun Göhring, Charlotte M. Niemeyer, Karin Nebral, Ingrid Simonitsch-Kluppp, Pascale De Paepe, Nadine Van Roy, Vít Campr, Zuzana Zemanová, Erik Clasen‐Linde, Tine Plesner, Brigitte Schlegelberger, Martina Rudelius, Kalliopi N. Manola, Kalliopi Stefanaki, Judit Csomor, Hajnalka Andrikovics, David R. Betts, Maureen J. O’Sullivan, Yaniv Zohar, Marta Jeison, Rita De Vito, Francesco Pasquali, Jadwiga Małdyk, Olga Haus, Helena Alaiz, Paula Kjöllerström, Luís Mascarenhas‐Lemos, Ivana Boďová, Martin Čermák, Lukáš Plank, Barbara Gazić, Marko Kavčič, Helena Podgornik, Margarita Llavador Ros, José Cervera, Carole Gengler, Joëlle Tchinda, Berna Beverloo, Roos J. Leguit, Marena R. Niewisch, Martin G. Sauer, Birgit Burkhardt, Peter Lang, Peter Bader, Rita Beier, Ingo Müller, Michael H. Albert, Roland Meisel, Ansgar Schulz, Gunnar Cario, Pritam Kumar Panda, Julius Wehrle, Shinsuke Hirabayashi, Marta Derecka, Robert Durruthy-Durruthy, Gudrun Göhring, Ayami Yoshimi‐Noellke, Manching Ku, Dirk Lebrecht, Miriam Erlacher, Christian Flotho, Brigitte Strahm, Charlotte M. Niemeyer, Marcin W. Włodarski - Nature Medicine 2021 cited by 168

  23. Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 64

  24. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanadi Rafii El-Ayoubi, Chantal Kenzey, Peter Bader, Franco Locatelli, Annalisa Ruggeri, Mary Eapen - Blood 2016 cited by 476